EXHI.US Exlites Holdings International Inc
- Market cap
- USD 15.4M
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jul 2026.
Is EXHI.US undervalued?
Graham numberThe Graham number of Exlites Holdings International Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Exlites Holdings International Inc fundamental analysis
No fundamental analysis for Exlites Holdings International Inc yet.
Exlites Holdings International Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Exlites Holdings International Inc
Exlites Holdings International, Inc. manufactures and distributes medical products. The company distributes and manufactures therapeutic pain, exercise, weight loss, and DVT prevention systems for use by patients. It sells proprietary patented and patent pending health care products, such as deep vein thrombosis units, transcutaneous electrical nerve stimulation units, electronic muscle stimulation units, various bracing products, and other medical and consumer healthcare pr…
Full company profileExlites Holdings International Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jul 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Exlites Holdings International Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 1995 | 1996 | 1997 | 1998 | 2015 | 2016 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.90M | 1.40M | 1.50M | 200K | 94.44 | 9.42K | 157K | 18.7K | 101K | 71.0K | 100K |
| Gross Profit | 100K | -100K | 800K | 100K | 57.74 | 829.17 | -38.1K | 18.7K | - | - | - |
| Operating Income | -1.70M | -2.00M | 1.70M | -300K | 10.59 | 6.86 | -342K | -15.5K | -21.0K | -43.5K | -25.0K |
| EBITDA | -1.60M | -1.90M | 1.80M | -200K | 10.59 | 6.86 | -342K | 77.4K | -21.0K | -43.5K | -25.0K |
| Net Income | 700K | 500K | -700K | -200K | -0.17 | 6.86 | -343K | -90.5K | -21.0K | -43.5K | -25.0K |
| EPS | - | - | - | -133,333 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | 3.80M | 4.40M | 3.20M | 3.20M | 192.59 | 373.06 | 648K | 446K | - | - | - |
| Total Liabilities | 800K | 900K | 400K | 200K | 318.88 | 457.33 | 145K | 33.8K | - | - | - |
| Shareholders' Equity | 3.00M | 3.50M | 2.80M | 3.00M | -126.29 | -84.26 | 502K | 412K | - | - | - |
| Cash & Short-term Investments | 500K | 200K | 300K | 1.20M | 17.86 | 24.78 | 15.1K | - | - | - | - |
| Total Debt | 300K | 400K | 200K | 211K | 250.00 | 325.00 | - | - | - | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 200K | 800K | -1.30M | 500K | 57.14 | -102.90 | -223K | -170K | - | - | - |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - |
| Free Cash Flow | 200K | 800K | -1.30M | 500K | 57.14 | -102.90 | -223K | -170K | - | - | - |
| Ratios | |||||||||||
| ROE | 23.3% | 14.3% | -25.0% | -6.7% | - | - | -68.2% | -22.0% | - | - | - |
| ROA | 18.4% | 11.4% | -21.9% | -6.3% | -0.1% | 1.8% | -52.9% | -20.3% | - | - | - |
| Net Profit Margin | 36.8% | 35.7% | -46.7% | -100.0% | -0.2% | 0.1% | -217.9% | -482.9% | -20.9% | -61.3% | -25.0% |
| Debt to Equity | 0.10x | 0.11x | 0.07x | 0.07x | - | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Exlites Holdings International Inc dividends
Exlites Holdings International Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 1:10 on Oct 11, 2023.
Who owns Exlites Holdings International Inc
Ownership data of Exlites Holdings International Inc is not available yet.
Exlites Holdings International Inc company profile
- Company name
- Exlites Holdings International Inc
- Ticker
- EXHI.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Fiscal year end
- January
- Address
- 8403 Benjamin Road, Tampa, FL, United States, 33634
- Phone
- 813-321-9551
- Website
- exlitesholdings.us
About Exlites Holdings International Inc
Exlites Holdings International, Inc. manufactures and distributes medical products. The company distributes and manufactures therapeutic pain, exercise, weight loss, and DVT prevention systems for use by patients. It sells proprietary patented and patent pending health care products, such as deep vein thrombosis units, transcutaneous electrical nerve stimulation units, electronic muscle stimulation units, various bracing products, and other medical and consumer healthcare products. The company also focuses on electric vehicle range extenders. The company was incorporated in 1979 and is based in Tampa, Florida.
Exlites Holdings International Inc management
1- Mark JulianPresident, CEO & Chairman